Sei Investments Co. Has $58.84 Million Stock Holdings in Waters Corporation $WAT

Posted by Brian Himes on Jul 26th, 2026

Sei Investments Co. raised its stake in Waters Corporation (NYSE:WAT – Free Report) by 162.7% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 197,565 shares of the medical instruments supplier’s stock after purchasing an additional 122,356 shares during the quarter. Sei Investments Co.’s holdings in Waters were worth $58,836,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in WAT. Zions Bancorporation National Association UT boosted its holdings in shares of Waters by 121.2% in the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 40 shares during the last quarter. SHP Wealth Management bought a new stake in Waters during the fourth quarter worth $32,000. DV Equities LLC acquired a new stake in Waters in the fourth quarter valued at $32,000. Anchor Investment Management LLC bought a new position in shares of Waters in the 1st quarter valued at about $27,000. Finally, Vision Retirement LLC bought a new position in shares of Waters in the 1st quarter valued at about $29,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Price Performance

Shares of Waters stock opened at $374.49 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $36.77 billion, a price-to-earnings ratio of 47.59, a price-to-earnings-growth ratio of 2.27 and a beta of 1.20. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $414.15. The company has a 50-day simple moving average of $365.23 and a two-hundred day simple moving average of $346.13.

Waters (NYSE:WAT – Get Free Report) last announced its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.20 billion. During the same quarter in the prior year, the business posted $2.25 EPS. The business’s revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Analysts forecast that Waters Corporation will post 14.51 EPS for the current year.

Wall Street Analyst Weigh In

WAT has been the topic of a number of research analyst reports. Evercore reaffirmed an “outperform” rating and issued a $410.00 target price on shares of Waters in a report on Monday, July 6th. Bank of America upped their price objective on Waters from $370.00 to $400.00 and gave the company a “neutral” rating in a research note on Tuesday, June 2nd. The Goldman Sachs Group raised their price objective on Waters from $380.00 to $425.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Wall Street Zen downgraded Waters from a “buy” rating to a “hold” rating in a research note on Monday, July 20th. Finally, JPMorgan Chase & Co. boosted their target price on Waters from $330.00 to $345.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Three analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, Waters presently has an average rating of “Moderate Buy” and a consensus price target of $401.60.

Read Our Latest Research Report on Waters

Waters Company Profile

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.

Sei Investments Co. Has $58.84 Million Stock Holdings in Waters Corporation $WAT

Waters Price Performance

Wall Street Analyst Weigh In

Waters Company Profile

See Also

You might be interested in: